M Madiyalakan

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Sorry, we do not have enough data to show an influence graph for this author.
Learn More
We have used antibody (MAb) specific to hypoglycosy-lated tumor associated MUC1 as a strategy to induce tumor specific immunity. Xenotypic IgG1 has been previously shown to induce T cell immunity targeting MUC1 in patients. We now describe MUC1 specific IgE to reprogram myeloid cells in the tumor microenvironment and modulate tumor specific immunity. To(More)
  • 1